FDA Inspection
Natco Pharma Ltd. - Chemical DivisionNatco Pharma Ltd. - Chemical Division – FDA Inspection, Aug 9, 2019
Record Details
This FDA Inspection record concerns Natco Pharma Ltd. - Chemical Division, with an inspection on August 9, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f3508ce8-cdfe-42a8-acd7-8d4dd110fcb9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099291
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Natco Pharma Ltd. - Chemical Division
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 13, 2025 | Not classified | Office of Inspections and Investigations | |
| February 16, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 13, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 24, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Natco Pharma Ltd. - Chemical Division
- FDA Inspection 1275209 - 2025-06-13
- FDA Inspection 1052872 - 2018-02-16
- FDA Inspection 903169 - 2014-10-13
- FDA Inspection 762071 - 2011-11-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.